Skip to content
10-Q

Quarterly Report

STEADYMED LTD.

0001104659-17-067725

← back to feed
Filed
Nov 13, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 1, 2017 26.56M sh
Shares Diluted Q3 2017 · Sep 30, 2017 28.24M sh
Shares Diluted Q3 2017 · Sep 30, 2017 23.7M sh
Shares Diluted Q3 2017 · Sep 30, 2016 17.65M sh
Shares Diluted Q3 2017 · Sep 30, 2016 14.95M sh
Capex Q3 2017 · Sep 30, 2017 $992K
Capex Q3 2017 · Sep 30, 2016 $1.16M
Operating Cash Flow Q3 2017 · Sep 30, 2017 −$17.96M
Operating Cash Flow Q3 2017 · Sep 30, 2016 −$18.79M
Cash And Equivalents Q3 2017 · Sep 30, 2017 $37.42M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $23.22M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $31.5M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $31.85M
Stockholders Equity Q3 2017 · Sep 30, 2017 $29.46M
Stockholders Equity Q3 2017 · Dec 31, 2016 $14.31M
Current Liabilities Q3 2017 · Sep 30, 2017 $3.64M
Current Liabilities Q3 2017 · Dec 31, 2016 $6.36M
Current Assets Q3 2017 · Sep 30, 2017 $38.12M
Current Assets Q3 2017 · Dec 31, 2016 $23.38M
Total Assets Q3 2017 · Sep 30, 2017 $43.92M
Total Assets Q3 2017 · Dec 31, 2016 $28.16M
Sga Expense Q3 2017 · Sep 30, 2017 $1.29M
Sga Expense Q3 2017 · Sep 30, 2017 $3.83M
Sga Expense Q3 2017 · Sep 30, 2016 $1.49M
Sga Expense Q3 2017 · Sep 30, 2016 $4.17M
Rd Expense Q3 2017 · Sep 30, 2017 $3.77M
Rd Expense Q3 2017 · Sep 30, 2017 $11.4M
Rd Expense Q3 2017 · Sep 30, 2016 $6.04M
Rd Expense Q3 2017 · Sep 30, 2016 $16.31M
Operating Income Q3 2017 · Sep 30, 2017 −$5.08M
Operating Income Q3 2017 · Sep 30, 2017 −$15.57M
Operating Income Q3 2017 · Sep 30, 2016 −$7.69M
Operating Income Q3 2017 · Sep 30, 2016 −$20.99M
Revenue Q3 2017 · Sep 30, 2017 $322K
Revenue Q3 2017 · Sep 30, 2017 $957K
Revenue Q3 2017 · Sep 30, 2016 $276K
Revenue Q3 2017 · Sep 30, 2016 $745K